Literature DB >> 6202681

Characterization of N-glycolyneuraminic acid-containing glycosphingolipids from a Marek's disease lymphoma-derived chicken cell line, MSB1, as tumor-associated heterophile Hanganutziu-Deicher antigens.

H Higashi, K Ikuta, S Ueda, S Kato, Y Hirabayashi, M Matsumoto, M Naiki.   

Abstract

Heterophile, Hanganutziu-Deicher (HD) antigen-active N-glycolylneuraminic acid-containing glycosphingolipids (GSLs) were detected as tumor-associated foreign antigens of a Marek's disease lymphoma-derived cell line, MSB1, by enzyme-immunoassay with chicken antibody against N-glycolylneuraminyl-lactosylceramide (anti-NeuGc-LacCer). At least three species of HD antigen-active GSLs were detected by two-dimensional thin-layer chromatography (TLC) combined with enzyme-immunoassay. The reactivities of the GSLs with anti-NeuGc-LacCer, their behaviors on two-dimensional TLC and the results of an endo-beta-galactosidase digestion study indicated that these three GSLs were NeuGc-LacCer (NeuGc alpha 2-2Gal beta 1-4Glc-Cer), NeuGc-nLcOse4Cer (NeuGc alpha 2-3Gal beta 1-4GlcNAc beta 1-3Gal beta 1-4Glc-Cer) and NeuGc-nLcOse6Cer (NeuGc alpha 2-3Gal beta 1-4GlcNAc beta 1-3Gal beta 1-4GlcNAc beta 1-3Gal beta 1-4Glc-Cer).

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6202681     DOI: 10.1093/oxfordjournals.jbchem.a134670

Source DB:  PubMed          Journal:  J Biochem        ISSN: 0021-924X            Impact factor:   3.387


  12 in total

1.  Purification, characterization and reconstitution of CMP-N-acetylneuraminate hydroxylase from mouse liver.

Authors:  P Schneckenburger; L Shaw; R Schauer
Journal:  Glycoconj J       Date:  1994-06       Impact factor: 2.916

2.  Two species of antiganglioside antibodies in a patient with a pharyngeal-cervical-brachial variant of Guillain-Barré syndrome.

Authors:  K Mizoguchi; A Hase; T Obi; H Matsuoka; M Takatsu; Y Nishimura; F Irie; Y Seyama; Y Hirabayashi
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-09       Impact factor: 10.154

3.  Developmentally regulated O-acetylated sialoglycans in the central nervous system revealed by a new monoclonal antibody 493D4 recognizing a wide range of O-acetylated glycoconjugates.

Authors:  G Zhang; L Ji; S Kurono; S C Fujita; S Furuya; Y Hirabayashi
Journal:  Glycoconj J       Date:  1997-11       Impact factor: 2.916

4.  Involvement of the acyl chain of ceramide in carbohydrate recognition by an anti-glycolipid monoclonal antibody: the case of an anti-melanoma antibody, M2590, to GM3-ganglioside.

Authors:  S Itonori; K Hidari; Y Sanai; M Taniguchi; Y Nagai
Journal:  Glycoconj J       Date:  1989       Impact factor: 2.916

5.  Antibody to phosphatidylinositol 4,5-bisphosphate inhibits oncogene-induced mitogenesis.

Authors:  K Fukami; K Matsuoka; O Nakanishi; A Yamakawa; S Kawai; T Takenawa
Journal:  Proc Natl Acad Sci U S A       Date:  1988-12       Impact factor: 11.205

6.  Detection of CMP-N-acetylneuraminic acid hydroxylase activity in fractionated mouse liver.

Authors:  L Shaw; R Schauer
Journal:  Biochem J       Date:  1989-10-15       Impact factor: 3.857

7.  Occurrence of a novel fucose-containing pentaglycosylceramide with blood-group-B active determinant in Xenopus blastula cells: its possible involvement in cell-cell adhesion.

Authors:  K Nomura; N Nakajo; K I Hidari; H Nomura; M Murata; M Suzuki; K Yamana; Y Hirabayashi
Journal:  Biochem J       Date:  1995-03-15       Impact factor: 3.857

8.  Isolation of three novel cholinergic neuron-specific gangliosides from bovine brain and their in vitro syntheses.

Authors:  F Irie; S Kurono; Y T Li; Y Seyama; Y Hirabayashi
Journal:  Glycoconj J       Date:  1996-04       Impact factor: 2.916

Review 9.  Involvement of a non-human sialic Acid in human cancer.

Authors:  Annie N Samraj; Heinz Läubli; Nissi Varki; Ajit Varki
Journal:  Front Oncol       Date:  2014-02-19       Impact factor: 6.244

Review 10.  Exploration of the Sialic Acid World.

Authors:  Roland Schauer; Johannis P Kamerling
Journal:  Adv Carbohydr Chem Biochem       Date:  2018-11-28       Impact factor: 12.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.